Annual EBIT
-$2.17 M
+$3.63 M+62.57%
December 31, 2023
Summary
- As of February 7, 2025, CRVO annual earnings before interest & taxes is -$2.17 million, with the most recent change of +$3.63 million (+62.57%) on December 31, 2023.
- During the last 3 years, CRVO annual EBIT has risen by +$13.80 million (+86.40%).
- CRVO annual EBIT is now -454.31% below its all-time high of $613.00 thousand, reached on December 1, 1998.
Performance
CRVO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$5.40 M
-$2.40 M-80.17%
September 30, 2024
Summary
- As of February 7, 2025, CRVO quarterly earnings before interest & taxes is -$5.40 million, with the most recent change of -$2.40 million (-80.17%) on September 30, 2024.
- Over the past year, CRVO quarterly EBIT has dropped by -$2.80 million (-107.96%).
- CRVO quarterly EBIT is now -133.70% below its all-time high of $16.01 million, reached on December 1, 2012.
Performance
CRVO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$7.83 M
-$2.72 M-53.31%
September 30, 2024
Summary
- As of February 7, 2025, CRVO TTM earnings before interest & taxes is -$7.83 million, with the most recent change of -$2.72 million (-53.31%) on September 30, 2024.
- Over the past year, CRVO TTM EBIT has dropped by -$4.49 million (-134.27%).
- CRVO TTM EBIT is now -152.43% below its all-time high of $14.93 million, reached on June 1, 2013.
Performance
CRVO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CRVO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.6% | -108.0% | -134.3% |
| 3 y3 years | +86.4% | -108.0% | -134.3% |
| 5 y5 years | +82.0% | -108.0% | -134.3% |
CRVO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +86.5% | -270.7% | at low | -260.3% | +52.0% |
| 5 y | 5-year | at high | +86.5% | -270.7% | at low | -260.3% | +56.2% |
| alltime | all time | -454.3% | +90.4% | -133.7% | +74.5% | -152.4% | +80.6% |
CervoMed EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.40 M(+80.2%) | -$7.83 M(+53.3%) |
| Jun 2024 | - | -$3.00 M(+15.4%) | -$5.10 M(+52.8%) |
| Mar 2024 | - | -$2.59 M(-182.1%) | -$3.34 M(+53.8%) |
| Dec 2023 | -$2.17 M(-62.6%) | $3.16 M(-218.1%) | -$2.17 M(-74.7%) |
| Sep 2023 | - | -$2.68 M(+117.3%) | -$8.60 M(+25.9%) |
| Jun 2023 | - | -$1.23 M(-13.7%) | -$6.83 M(-30.6%) |
| Mar 2023 | - | -$1.43 M(-56.3%) | -$9.84 M(-24.1%) |
| Dec 2022 | -$5.80 M(-63.8%) | - | - |
| Dec 2022 | - | -$3.27 M(+261.2%) | -$12.97 M(-1.5%) |
| Sep 2022 | - | -$904.10 K(-78.7%) | -$13.17 M(-19.3%) |
| Jun 2022 | - | -$4.25 M(-6.8%) | -$16.32 M(+2.6%) |
| Mar 2022 | - | -$4.55 M(+31.4%) | -$15.91 M(-0.8%) |
| Dec 2021 | -$16.04 M(+0.4%) | -$3.47 M(-14.5%) | -$16.04 M(-3.7%) |
| Sep 2021 | - | -$4.05 M(+5.8%) | -$16.66 M(-6.8%) |
| Jun 2021 | - | -$3.83 M(-18.2%) | -$17.88 M(+1.0%) |
| Mar 2021 | - | -$4.68 M(+14.6%) | -$17.70 M(+10.8%) |
| Dec 2020 | -$15.97 M(+38.3%) | -$4.09 M(-22.5%) | -$15.97 M(+7.6%) |
| Sep 2020 | - | -$5.27 M(+44.2%) | -$14.85 M(+17.6%) |
| Jun 2020 | - | -$3.66 M(+23.8%) | -$12.63 M(+9.0%) |
| Mar 2020 | - | -$2.96 M(-0.1%) | -$11.59 M(+0.3%) |
| Dec 2019 | -$11.55 M(-4.0%) | -$2.96 M(-3.0%) | -$11.55 M(+1.3%) |
| Sep 2019 | - | -$3.05 M(+16.4%) | -$11.41 M(+2.4%) |
| Jun 2019 | - | -$2.62 M(-10.2%) | -$11.14 M(-3.9%) |
| Mar 2019 | - | -$2.92 M(+3.7%) | -$11.60 M(-3.6%) |
| Dec 2018 | -$12.03 M(+6.0%) | -$2.81 M(+1.0%) | -$12.03 M(+3.1%) |
| Sep 2018 | - | -$2.79 M(-9.5%) | -$11.67 M(-4.6%) |
| Jun 2018 | - | -$3.08 M(-8.1%) | -$12.23 M(+0.8%) |
| Mar 2018 | - | -$3.35 M(+36.6%) | -$12.13 M(+6.9%) |
| Dec 2017 | -$11.35 M(-38.2%) | -$2.45 M(-26.7%) | -$11.35 M(-0.8%) |
| Sep 2017 | - | -$3.35 M(+12.2%) | -$11.44 M(-17.7%) |
| Jun 2017 | - | -$2.98 M(+16.1%) | -$13.89 M(-5.6%) |
| Mar 2017 | - | -$2.57 M(+1.0%) | -$14.71 M(-19.9%) |
| Dec 2016 | -$18.37 M(+186.8%) | -$2.54 M(-56.2%) | -$18.36 M(-0.1%) |
| Sep 2016 | - | -$5.80 M(+52.6%) | -$18.39 M(+32.0%) |
| Jun 2016 | - | -$3.80 M(-38.9%) | -$13.94 M(+21.9%) |
| Mar 2016 | - | -$6.22 M(+142.2%) | -$11.44 M(+78.5%) |
| Dec 2015 | -$6.41 M(-62.1%) | -$2.57 M(+90.8%) | -$6.41 M(-43.5%) |
| Sep 2015 | - | -$1.35 M(+3.7%) | -$11.35 M(-16.0%) |
| Jun 2015 | - | -$1.30 M(+8.8%) | -$13.51 M(-19.2%) |
| Mar 2015 | - | -$1.19 M(-84.1%) | -$16.72 M(-0.8%) |
| Dec 2014 | -$16.90 M | -$7.51 M(+114.0%) | -$16.84 M(+56.7%) |
| Sep 2014 | - | -$3.51 M(-22.1%) | -$10.75 M(+21.4%) |
| Jun 2014 | - | -$4.51 M(+240.8%) | -$8.85 M(+382.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$1.32 M(-6.3%) | -$1.84 M(-35.4%) |
| Dec 2013 | -$2.84 M(-57.5%) | -$1.41 M(-12.6%) | -$2.84 M(-119.5%) |
| Sep 2013 | - | -$1.61 M(-164.3%) | $14.58 M(-2.3%) |
| Jun 2013 | - | $2.51 M(-207.9%) | $14.93 M(-271.5%) |
| Mar 2013 | - | -$2.33 M(-114.5%) | -$8.70 M(+30.3%) |
| Dec 2012 | -$6.68 M(-70.4%) | $16.01 M(-1361.0%) | -$6.68 M(-82.1%) |
| Sep 2012 | - | -$1.27 M(-94.0%) | -$37.43 M(-7.1%) |
| Jun 2012 | - | -$21.12 M(+6828.7%) | -$40.30 M(+89.8%) |
| Mar 2012 | - | -$304.80 K(-97.9%) | -$21.24 M(-6.1%) |
| Dec 2011 | -$22.61 M(+171.4%) | -$14.73 M(+255.9%) | -$22.61 M(+95.9%) |
| Sep 2011 | - | -$4.14 M(+101.3%) | -$11.54 M(+27.6%) |
| Jun 2011 | - | -$2.06 M(+22.8%) | -$9.04 M(+2.7%) |
| Mar 2011 | - | -$1.67 M(-54.4%) | -$8.81 M(+5.7%) |
| Dec 2010 | -$8.33 M(+154.0%) | -$3.67 M(+123.3%) | -$8.33 M(+33.1%) |
| Sep 2010 | - | -$1.64 M(-9.7%) | -$6.26 M(+20.8%) |
| Jun 2010 | - | -$1.82 M(+52.2%) | -$5.18 M(+36.8%) |
| Mar 2010 | - | -$1.20 M(-25.2%) | -$3.79 M(+27.4%) |
| Dec 2009 | -$3.28 M(+171.5%) | -$1.60 M(+181.6%) | -$2.97 M(+65.3%) |
| Sep 2009 | - | -$567.80 K(+33.4%) | -$1.80 M(+18.4%) |
| Jun 2009 | - | -$425.70 K(+11.8%) | -$1.52 M(+14.5%) |
| Mar 2009 | - | -$380.90 K(-10.3%) | -$1.33 M(+9.9%) |
| Dec 2008 | -$1.21 M(+2063.8%) | -$424.60 K(+47.3%) | -$1.21 M(-4007.1%) |
| Sep 2008 | - | -$288.20 K(+23.5%) | $30.90 K(-81.7%) |
| Jun 2008 | - | -$233.30 K(-10.7%) | $169.30 K(+125.4%) |
| Mar 2008 | - | -$261.20 K(-132.1%) | $75.10 K(-234.6%) |
| Dec 2007 | -$55.80 K(+33.2%) | $813.60 K(-643.1%) | -$55.80 K(-93.8%) |
| Sep 2007 | - | -$149.80 K(-54.3%) | -$900.50 K(+19.4%) |
| Jun 2007 | - | -$327.50 K(-16.5%) | -$754.30 K(+60.0%) |
| Mar 2007 | - | -$392.10 K(+1160.8%) | -$471.50 K(+468.1%) |
| Dec 2006 | -$41.90 K(-54.6%) | -$31.10 K(+763.9%) | -$83.00 K(+59.9%) |
| Sep 2006 | - | -$3600.00(-91.9%) | -$51.90 K(+7.5%) |
| Jun 2006 | - | -$44.70 K(+1141.7%) | -$48.30 K(+1241.7%) |
| Mar 2006 | - | -$3600.00(-99.9%) | -$3600.00(-100.0%) |
| Dec 2005 | -$92.20 K(-98.7%) | - | - |
| Sep 2000 | - | -$4.24 M(+259.1%) | -$12.06 M(+32.3%) |
| Jun 2000 | - | -$1.18 M(-2.5%) | -$9.12 M(+6.2%) |
| Mar 2000 | - | -$1.21 M(-77.7%) | -$8.58 M(+18.0%) |
| Dec 1999 | -$7.22 M(-1278.5%) | -$5.42 M(+317.2%) | -$7.27 M(+257.3%) |
| Sep 1999 | - | -$1.30 M(+100.4%) | -$2.04 M(+367.2%) |
| Jun 1999 | - | -$648.70 K(-748.7%) | -$435.70 K(-304.6%) |
| Mar 1999 | - | $100.00 K(-153.5%) | $213.00 K(+88.5%) |
| Dec 1998 | $613.00 K | -$187.00 K(-162.3%) | $113.00 K(-62.3%) |
| Sep 1998 | - | $300.00 K | $300.00 K |
FAQ
- What is CervoMed annual earnings before interest & taxes?
- What is the all time high annual EBIT for CervoMed?
- What is CervoMed annual EBIT year-on-year change?
- What is CervoMed quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for CervoMed?
- What is CervoMed quarterly EBIT year-on-year change?
- What is CervoMed TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for CervoMed?
- What is CervoMed TTM EBIT year-on-year change?
What is CervoMed annual earnings before interest & taxes?
The current annual EBIT of CRVO is -$2.17 M
What is the all time high annual EBIT for CervoMed?
CervoMed all-time high annual earnings before interest & taxes is $613.00 K
What is CervoMed annual EBIT year-on-year change?
Over the past year, CRVO annual earnings before interest & taxes has changed by +$3.63 M (+62.57%)
What is CervoMed quarterly earnings before interest & taxes?
The current quarterly EBIT of CRVO is -$5.40 M
What is the all time high quarterly EBIT for CervoMed?
CervoMed all-time high quarterly earnings before interest & taxes is $16.01 M
What is CervoMed quarterly EBIT year-on-year change?
Over the past year, CRVO quarterly earnings before interest & taxes has changed by -$2.80 M (-107.96%)
What is CervoMed TTM earnings before interest & taxes?
The current TTM EBIT of CRVO is -$7.83 M
What is the all time high TTM EBIT for CervoMed?
CervoMed all-time high TTM earnings before interest & taxes is $14.93 M
What is CervoMed TTM EBIT year-on-year change?
Over the past year, CRVO TTM earnings before interest & taxes has changed by -$4.49 M (-134.27%)